NORDH — Nordhealth AS Share Price
0.000.00%
Last trade - 00:00- NOK3.43bn
- NOK3.20bn
- €36.83m
- 62
- 10
- 87
- 52
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.81 | ||
| Price to Tang. Book | 14.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.67 | ||
| EV to EBITDA | 168 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -11.94% | ||
| Return on Equity | -10.05% | ||
| Operating Margin | -20.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | 12.69 | 20.3 | 31.05 | 36.83 | 45.04 | 52.46 | 42.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nordhealth AS is a Norway-based cloud-based healthcare Software-as-a-Service business. The Company's flagship products are Provet Cloud and Diarium, both cloud-based Practice Management Software for veterinarians and therapists, respectively. The Group serves over 7,000 clinics and hospitals located in over 25 countries. Nordhealth's mission is to build software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- April 21st, 2021
- Public Since
- June 3rd, 2021
- No. of Employees
- 403
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Oslo Stock Exchange
- Shares in Issue
- 79,065,908
- Address
- NA02, MOLDE, 6422
- Web
- https://nordhealth.com/
- Phone
- +47 23111111
- Contact
- Charles MacBain
- Auditors
- KPMG AS
Upcoming Events for NORDH
Similar to NORDH
Codelab Capital AS
Oslo Stock Exchange
ContextVision AB
Oslo Stock Exchange
Gentian Diagnostics ASA
Oslo Stock Exchange
INIFY Laboratories AB
Oslo Stock Exchange
Medistim ASA
Oslo Stock Exchange
FAQ
What is the Nordhealth AS share price?
As of Today at 21:19 UTC, shares in Nordhealth AS are trading at NOK43.40. This share price information is delayed by 15 minutes.
How has the Nordhealth AS share price performed this year?
Shares in Nordhealth AS last closed at NOK43.40 and the price had moved by +75.21% over the past 365 days. In terms of relative price strength the Nordhealth AS share price has outperformed the FTSE Global All Cap Index by +58.23% over the past year.
What are the analyst and broker recommendations for Nordhealth AS?
The overall consensus recommendation for Nordhealth AS is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Nordhealth AS dividend yield?
Nordhealth AS does not currently pay a dividend.
Does Nordhealth AS pay a dividend?
Nordhealth AS does not currently pay a dividend.
When does Nordhealth AS next pay dividends?
Nordhealth AS does not currently pay a dividend.
How do I buy Nordhealth AS shares?
To buy shares in Nordhealth AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nordhealth AS?
As of the previous close price of NOK43.40, shares in Nordhealth AS had a market capitalisation of NOK3.43bn.
Where are Nordhealth AS shares listed?
Here are the trading details for Nordhealth AS:
- Country of listing: Norway
- Exchange: OSL
- Ticker Symbol: NORDH
What kind of share is Nordhealth AS?
Based on an overall assessment of its quality, value and momentum Nordhealth AS is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nordhealth AS share price forecast for 2024?
The analyst consensus target price for shares in Nordhealth AS is NOK46.00. That is 5.99% above the last closing price of NOK43.40.
Analysts covering Nordhealth AS currently have a consensus Earnings Per Share (EPS) forecast of -€0.10 for the next financial year.
Find out moreWhat is the trend in the Nordhealth AS share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nordhealth AS. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +19.1%.
As of the last closing price of NOK43.40, shares in Nordhealth AS were trading +31.58% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nordhealth AS PE Ratio?
The Nordhealth AS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NOK43.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nordhealth AS?
We do not have data on Nordhealth AS' directors